AvidBiotics
South San Francisco, California, United States
About AvidBiotics
AvidBiotics is a biotherapeutics company deploying a proprietary biotechnology-derived technology platform that has multiple applications in life sciences. The company develops novel, non-antibody proteins used to target bacteria, virus-infected cells, and cancers. Its portfolio of therapeutic protein candidates and protein engineering platforms specifically flags virus-infected or cancerous cells for enhanced destruction by the Natural Killer and T-cells of the potent innate immunity systems and focuses on human therapeutic applications of its technologies that enable physicians to activate the immune system to target and destroy cancer cells infected by viruses with laser precision.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.7M
- Last round: Series Unknown (Sep 2014)
- Website: avidbiotics.com
- Phone: 6508731010
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/avidbiotics-2459853 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.